105 related articles for article (PubMed ID: 6582683)
1. [Use of prolonged intravenous infusions of cisplatin in patients with malignant neoplasms].
Tiuliadin SA
Vopr Onkol; 1983; 29(12):40-4. PubMed ID: 6582683
[TBL] [Abstract][Full Text] [Related]
2. Continuous or repeated prolonged cisplatin infusions in children: a prospective study on ototoxicity, platinum concentrations, and standard serum parameters.
Lanvers-Kaminsky C; Krefeld B; Dinnesen AG; Deuster D; Seifert E; Würthwein G; Jaehde U; Pieck AC; Boos J
Pediatr Blood Cancer; 2006 Aug; 47(2):183-93. PubMed ID: 16302218
[TBL] [Abstract][Full Text] [Related]
3. Cis-diamminedichloroplatinum (NSC-119875): a phase I study.
Higby DJ; Wallace HJ; Holland JF
Cancer Chemother Rep; 1973; 57(4):459-63. PubMed ID: 4586953
[No Abstract] [Full Text] [Related]
4. Pharmacokinetic evaluation of cisplatin in children with malignant solid tumors: a phase II study.
Pratt CB; Hayes A; Green AA; Evans WE; Senzer N; Howarth CB; Ransom JL; Crom W
Cancer Treat Rep; 1981; 65(11-12):1021-6. PubMed ID: 7197583
[TBL] [Abstract][Full Text] [Related]
5. [cis-Diamino-dichloro-platinum (II) in the treatment of otherwise treatment-resistant malignant testicular teratoma (author's transl)].
Osieka R; Bruntsch U; Gallmeier WM; Seeber S; Schmidt CG
Dtsch Med Wochenschr; 1976 Feb; 101(6):191-5, 199. PubMed ID: 1248396
[TBL] [Abstract][Full Text] [Related]
6. [Cis-dichlorodiammineplatinum in osteosarcoma. Osteosarcoma Cooperative Study Group report].
Fukuma H; Beppu Y; Chuman H; Yagi T; Yamawaki S; Isu K; Funayama K; Tanuma M; Abe Y; Toriyama S
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 1):811-7. PubMed ID: 2653222
[TBL] [Abstract][Full Text] [Related]
7. Clinical evaluation of toxic effects of cis-diamminedichloroplatinum (NSC-119875)--phase I clinical study.
Talley RW; O'Bryan RM; Gutterman JU; Brownlee RW; McCredie KB
Cancer Chemother Rep; 1973; 57(4):465-71. PubMed ID: 4762440
[No Abstract] [Full Text] [Related]
8. cis-Diamminedichloroplatinum(II) alone and in combination in the treatment of testicular and other malignancies.
Sarna G; Skinner DG; Smith RB; Zighelboim J; Goodnight JE; Feig S
Cancer Treat Rep; 1980; 64(10-11):1077-82. PubMed ID: 7193086
[TBL] [Abstract][Full Text] [Related]
9. Phase II study of paclitaxel and cisplatin in patients with non-small cell lung cancer.
von Pawel J; Wagner H; Niederle N; Heider A; Koschel G; Hecker D; Hanske M
Semin Oncol; 1996 Dec; 23(6 Suppl 16):47-50. PubMed ID: 9007121
[TBL] [Abstract][Full Text] [Related]
10. [Effect of cis-platinum in neuroblastoma].
Nakadate H; Nishi M; Hattori T; Hatae Y; Takeda T
Gan To Kagaku Ryoho; 1985 Jan; 12(1):147-50. PubMed ID: 4038446
[TBL] [Abstract][Full Text] [Related]
11. Phase II trial of topotecan administered as 72-hour continuous infusion in children with refractory solid tumors: a collaborative Pediatric Branch, National Cancer Institute, and Children's Cancer Group Study.
Blaney SM; Needle MN; Gillespie A; Sato JK; Reaman GH; Berg SL; Adamson PC; Krailo MD; Bleyer WA; Poplack DG; Balis FM
Clin Cancer Res; 1998 Feb; 4(2):357-60. PubMed ID: 9516923
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of postoperative nausea and vomiting with ondansetron in patients administered anti-neoplastic agents].
Morimoto Y; Nakamura M; Tamura T; Kunii T; Shimizu K; Miyauchi Y
Masui; 1996 Sep; 45(9):1096-9. PubMed ID: 8905945
[TBL] [Abstract][Full Text] [Related]
13. [Phase II study on cis-diamminedichloroplatinum (II) by a collaborative study].
Gan To Kagaku Ryoho; 1982 Jan; 9(1):46-54. PubMed ID: 6892191
[TBL] [Abstract][Full Text] [Related]
14. Application of cisplatin as intraoperative hyperthermic peritoneal lavage (IHPL) in patients with locally advanced gastric cancer: analysis of pharmacokinetics and of nephrotoxicity.
Kern W; Braess J; Kotschofsky M; Samel S; Becker H; Hiddemann W; Schleyer E
Anticancer Res; 2002; 22(5):3099-102. PubMed ID: 12530050
[TBL] [Abstract][Full Text] [Related]
15. Dose-escalated paclitaxel in 1-hour infusion with a fixed dose of cisplatin in previously untreated advanced ovarian cancer: a phase II trial of the Spanish Group for Ovarian Cancer.
Cervantes A; Mendiola C; del Campo JM; Massuti B; Casado A; Escobedo A; Moyano A; Ojeda B; Poveda A; Benito D
Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-40-S15-43. PubMed ID: 9346221
[TBL] [Abstract][Full Text] [Related]
16. [The effect of platinum diamminodichloride (cis-platinum) in the treatment of metastasized testicular teratoma].
Stoter G; Vendrik CP; Struyvenberg A; Pinedo HM
Ned Tijdschr Geneeskd; 1978 Jul; 122(28):1015-20. PubMed ID: 353570
[No Abstract] [Full Text] [Related]
17. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
[TBL] [Abstract][Full Text] [Related]
18. Antiemetic effect of ondansetron and dexamethasone in gynecologic malignant patients receiving chemotherapy.
Pradermdee P; Manusirivithaya S; Tangjitgamol S; Thavaramara T; Sukwattana P
J Med Assoc Thai; 2006 Oct; 89 Suppl 4():S29-36. PubMed ID: 17725140
[TBL] [Abstract][Full Text] [Related]
19. Cis-diamminedichloroplatinum (II) by 5-day continuous infusion. A new dose schedule with minimal toxicity.
Salem P; Khalyl M; Jabboury K; Hashimi L
Cancer; 1984 Feb; 53(4):837-40. PubMed ID: 6537893
[TBL] [Abstract][Full Text] [Related]
20. Weekly cisplatin paclitaxel and continuous infusion fluorouracil in patients with recurrent and/or metastatic head and neck squamous cell carcinoma: a phase II study.
Schena M; Barone C; Birocco N; Dongiovanni D; Numico G; Colantonio I; Bertetto O
Cancer Chemother Pharmacol; 2005 Mar; 55(3):271-6. PubMed ID: 15592837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]